Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients

Diabetologia

Volumn 43, Issue 5, 2000, Pages 598-608

  Roll, U ^c   Turck, C W ^c   Gitelman, S E ^c   Rosenthal, S M ^c   Nolte, M S ^c   Masharani, U ^c   Ziegler, A G ^a   Baekkeskov, S ^b  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

38 000 M(r) autoantigen; Autoantibodies; Deglycation; Glima 38; Immunology; Lectin binding; Peptide mapping; Proteolytic cleavage; Target autoantigen; Type I diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; MEMBRANE PROTEIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET BETA CELL; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, AFFINITY; DIABETES MELLITUS, TYPE 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASES; FEMALE; GLYCOSYLATION; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; MEMBRANE PROTEINS; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN CONFORMATION; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0034027319     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051349     Document Type: Article

References (32)

1. 1. Ziegler AG, Eisenbarth GS (1990) Immunology of diabetes. In: Alberti KGMM, Krall PS (eds) Diabetes Annual 5. Elsevier, Amsterdam, pp 20-50
2. 2. Roll U, Ziegler AG (1997) Combined antibody screening for improved prediction of IDDM - Modern strategies. Exp Clin Endocrinol Diabetes 105:1-14
3. 3. Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156
4. 4. Aanstoot HJ, Kang SM, Kim J et al. (1996) Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 -marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97: 2772-2783
5. 5. Hawa M, Rowe R, Lan MS et al. (1997) Value of antibodies to islet protein tyrosine phophatase-like molecule in predicting type 1 diabetes. Diabetes 48: 1270-1275
6. 6. Rabin DU, Pleasic SM, Shapiro JA et al. (1994) Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152: 3183-3188
7. 7. Payton M, Hawkes C, Christie MR (1996) Relationship of the 37,000- and 40,000-Mr tryptic fragment of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96: 1506-1511
8. 8. Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, Rogge L (1995) The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci USA 92: 9412-9416
9. 9. Lan MS, Wasserfall C, Maclaren NK, Notkins AL (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 93: 6367-6370
10. 10. Baekkeskov S, Warnock G, Christie M, Rajotte RV, Larsen PM, Fey S (1989) Revelation of specificity of 64 K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes 38: 1133-1141
11. 11. Roep BO, Arden SA, de Vries RRP, Hutton JC (1990) T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632-634
12. 12. Pak CY, Cha CY, Rajotte RV, McArthur RG, Yoon JW (1990) Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 33: 596-572
13. 13. Honeyman MC, Cram DS, Harrison LC (1993) Transcription factor jun-B is a target of autoreactive T-cells in IDDM. Diabetes 42: 626-630
14. 14. Ko IY, Jun HS, Kim GS, Yoon JW (1994) Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat. Diabetologia 37: 460-465
15. 15. Arden SD, Roep BO, Neophytou PI et al. (1996) Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 97: 551-561
16. 16. Ko IY, Ihm S, Yoon JW (1991) Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta cell-dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats. Diabetologia 34: 548-554
17. 17. World Health Organization (1985) Diabetes Mellitus: Report of a WHO Study Group. WHO Technical Report Series 727, World Health Organization, Geneva
18. 18. Seidel DK, Geiss HC, Donner MG et al. (1998) Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes. J Autoimmun 11: 273-277
19. 19. Efrat S, Linde S, Kofod H et al. (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin-oncogene. Proc Natl Acad Sci USA 85: 9037-9041
20. 20. Martinez de la Escalera G, Choi AL, Weiner RI (1990) Generation and synchronization of gonadotropin-releasing hormone (GnRH) pulses: intrinsic properties of the GT1-1 GnRH neuronal cell line. Proc Natl Acad Sci USA 89: 1852-1855
21. 21. Bordier C (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256: 1604-1607
22. 22. Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15: 429-436
23. 23. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 433-350
24. 24. Verge CF, Stenger D, Bonifacio E et al (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Diabetes 47: 1857-1866
25. 25. Elbein AD (1984) Inhibitors of the biosynthesis and processing of N-linked oligosaccharides. CRC Crit Rev Biochem 16: 21-49
26. 26. Schrägger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 10 kDa. Anal Biochem 166: 368-379
27. 27. Rademacher TW, Parekh RB, Dwek RA (1988) Glycobiology. Annu Rev Biochem 57: 785-838
28. 28. Wagh PV, Bahl OP (1981) Sugar residues on proteins. CRC Crit Rev Biochem 10: 307-377
29. 29. Batstra MR, Petersen JS, Verwest AM et al. (1998) Autoantibodies to glima 38, glutamic acid decarboxylase and IA2 in healthy schoolchildren. Diabetes 47[Suppl]:A206 (Abstract)
30. 30. Lennarz WJ (1987) Protein glycosylation in the endoplasmic reticulum. Biochemistry 26: 7205-7210
31. 31. Lan M, Lu J, Goto Y, Notkins AL (1994) Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13: 505-514
32. 32. Lotan R, Nicolson GL (1979) Purification of cell membrane glycoproteins by lectin affinity chromatograph. Biochim Biophys Acta 559: 329-376